Inogen, Inc (INGN) Financials
INGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 343.7 million | 113.1 million |
2023-06-30 | 374.4 million | 99.6 million |
2023-03-31 | 385.7 million | 104.4 million |
2022-12-31 | 405.0 million | 107.6 million |
INGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.1 million | 1.8 million |
2023-06-30 | -4.6 million | 3.3 million |
2023-03-31 | -13.1 million | 3.4 million |
2022-12-31 | -22.6 million | 3.1 million |
INGN Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-09-30 | -45.7 million |
2023-06-30 | -9.8 million |
2023-03-31 | -20.3 million |
2022-12-31 | -56.6 million |
INGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 138.0 million | - | 22.8 million |
2023-06-30 | 170.1 million | - | 21.9 million |
2023-03-31 | 174.6 million | - | 22.7 million |
2022-12-31 | 187.0 million | - | 23.3 million |
INGN Shares Outstanding
INGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 5.3 million | 4.5 million | 17.0 million | 26.1 million |
2023-06-30 | 8.6 million | 4.3 million | 14.6 million | 26.9 million |
2023-03-31 | 6.8 million | 5.3 million | 18.9 million | 28.4 million |
2022-12-31 | 7.1 million | 5.9 million | 1.3 million | 28.6 million |
INGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 84.0 million | 50.2 million |
2023-06-30 | 83.6 million | 49.6 million |
2023-03-31 | 72.2 million | 41.4 million |
2022-12-31 | 88.1 million | 58.6 million |
INGN
Price: $7.41
52 week price:
Earnings Per Share: -4.42 USD
P/E Ratio: -1.33
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 86424
Ebitda: 11.8 millionMarket Capitalization: 172.6 million